Methyl 5-bromo-8-hydroxy-1,6-naphthyridine-7-carboxylate, 95.0%, 250mg

(1S,4R)-4-((((9H-Fluoren-9-yl)methoxy)carbonyl)amino)cyclopent-2-enecarboxylic acid, 95.0%, 100mg

2-(4-Methylpiperazin-1-yl)benzonitrile, 95.0%, 25g

methyl 1-(2-bromophenyl)cyclopropane-1-carboxylate, 98%, 1g

1-Methyl-4-((trifluoromethyl)sulfonyl)benzene, 95.0%, 250mg

2-(2,3-Dihydrobenzo[b][1,4]dioxin-6-yl)acetic acid, 95.0%, 1g

4-Chloro-7-((2-(trimethylsilyl)ethoxy)methyl)-7H-pyrrolo[2,3-d]pyrimidine, 95.0%, 25g

Sodium 1-naphthalenesulfonate, 97.0%, 100g

1-BOC-3-ETHYNYL-3-METHYLAZETIDINE, 95.0%, 1g

4-(Pentafluoroethyl)benzonitrile, 95.0%, 250mg

1-Methyl-1,7-diazaspiro[3.5]nonane dihydrochloride, 97%, 1g

Methyl 3-hydroxybutanoate, 97%, 1kg

1,3-dimethylbarbituric acid, min. 98%, for synthesis, 25 g, plastic packaging.